Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Ranking and Category

  • 134th of 145 in

    Endocrinology & Metabolism

  • 148th of 158 in

    Immunology

  • 237th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 10 - Number 3








Metabolic Acidosis in Sepsis

, 10(3): 252 - 257

Alexandre Toledo Maciel, Danilo Teixeira Noritomi and Marcelo Park


DOI: 10.2174/187153010791936900


Lipid-Activated Nuclear Receptors and Sepsis

, 10(3): 258 - 265

Thais Martins de Lima-Salgado, Luiz Monteiro Cruz and Heraldo Possolo Souza


DOI: 10.2174/187153010791936937


Corticosteroids in Sepsis: Pathophysiological Rationale and the Selection of Patients

, 10(3): 266 - 273

Jorge Ibrain Figueira Salluh, Fernando Augusto Bozza, Andre Miguel Japiassu, Hugo Caire Castro Faria Neto, Patricia Torres Bozza and Pedro Povoa


DOI: 10.2174/187153010791936865







Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.

Related Journals

Related eBooks

eBooks Catalog